<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

Pharmacy News and Stories

Graduate Program

Research    Alumni    Pharmacy    Clinical Research    Graduate Program

CU Pharmacy Alumnus Strategizes through PhD Program


Recently, we connected with Dr. Chong Kim (CK), who received his PhD in Pharmaceutical Outcomes during the fall 2020 Commencement on Dec. 12. Dr. Kim  describes himself as a critical thinking, highly motivated, and hard working problem solver. Currently, his specific interests lie in optimizing the landscape of the healthcare environment around the world. His main expertise involves observational studies, development of statistical methods, and programming. He's currently working as a manager at Stratevi.

Author Jaron Bryant | Publish Date May 28, 2021
Full Story

School of Pharmacy In the News

Medscape

Medical Cannabis for Chronic Pain Tied to Arrhythmia Risk

news outletMedscape
Publish DateFebruary 13, 2024

Adults using medical cannabis for chronic pain, especially those with cancer or cardiometabolic disease, have a slightly elevated risk of developing arrhythmia, according to an editorial by Robert Page, PharmD

Full Story
KDVR

Colorado company developing potential prescription psilocybin product

news outletKDVR
Publish DateJanuary 17, 2024

Dr. David Kroll, PhD, says right now psilocybin is listed as a schedule one drug with no medical benefit and a high potential for abuse. “So, it is a risky proposition for these companies," he said, "but the clinical trials that have come out to date have been so promising that these companies have been able to acquire investors."

Full Story
The Denver Post

Littleton company developing psilocybin microdosing drug in hopes of FDA approval

news outletThe Denver Post
Publish DateJanuary 09, 2024

Though they hope to gain FDA approval soon, it may take some time. Dr. David Kroll, PhD, said the company will have additional hurdles to clear with the agency. 

Full Story
Neurology Today

Neurology Drugs Are Getting Better—and More Expensive—With More Prior Authorization Hassles

news outletNeurology Today
Publish DateJanuary 04, 2024

“The payers are trying to squeeze wherever they can,” said Dr. Kavita Nair, PhD, FAAN, a neurology professor and pharmacy outcomes researcher at the University of Colorado and vice chair of the American Academy of Neurology's Coding and Payment Policy Subcommittee.

Full Story